Results 291 to 300 of about 936,897 (362)
Interfacial Interaction‐Mediated Regulation of Metal Oxidation States for Enhanced CO2 Reduction
A hybrid strategy is employed to optimize bismuth–oxygen interactions, precisely regulating interfacial bismuth–oxygen bonds during topochemical synthesis. This leads to vanadium oxynitride‐bismuth catalyst exhibiting high Faradaic efficiency and durability for formate production, attributed to enhanced reaction thermodynamics and kinetics.
Zhongyuan Ma+6 more
wiley +1 more source
Emerging therapies for childhood-onset movement disorders. [PDF]
Vogt L, Quiroz V, Ebrahimi-Fakhari D.
europepmc +1 more source
The Angiopep‐2 peptide density on polymeric nanoparticles significantly impacts blood–brain barrier (BBB) penetration. This study explores this nuanced relationship using various in vitro models and in vivo assays, revealing that dynamic models better predict BBB penetration.
Weisen Zhang+9 more
wiley +1 more source
Functional Movement Disorders: Updates and Clinical Overview. [PDF]
Park JE.
europepmc +1 more source
Low‐dimensional halide perovskite thin films, (BA)2(MA)n‐1PbnBr3n+1 (n = 1, 2), exhibit both semiconducting and ferroelectric properties, enabling mechanical and light energy harvesting. Using Cr/Cr₂O₃ or PCBM as barrier layers ensures reproducible ferroelectricity.
Raja Sekhar Muddam+8 more
wiley +1 more source
Editorial: Remote monitoring technologies in neurodegenerative movement disorders. [PDF]
Oyama G+3 more
europepmc +1 more source
This work explores Li‐substituted P2 layered oxides for Na‐ion batteries by crystallographic and electrochemical studies. The effect of lithium on superstructure orderings, on phase transitions during synthesis and electrochemical cycling and on the interplay of O‐ versus TM‐redox is revealed via various advanced techniques, including semi‐simultaneous
Mingfeng Xu+5 more
wiley +1 more source
Outcome Selection for Research Studies in Movement Disorders. [PDF]
Fox SH.
europepmc +1 more source
Oct4‐nanoscript, a biomimetic nanoparticle‐based artificial transcription factor, precisely regulates cellular rejuvenation by activating Oct4 target genes, restoring epigenetic marks, and reducing DNA damage. In a progeria model, it effectively rescued aging‐associated pathologies and extended lifespan.
Hongwon Kim+8 more
wiley +1 more source